| Prolymphocytic Leukemia studied in …STUDIED_INderived95 of 95show fewer |
|---|
| → studied in | NCT05010005Phase 1 · recruiting A Study of Ruxolitinib and Duvelisib in People With Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07311746Phase 1/Phase 2 · recruiting Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810778Phase 1/Phase 2 · recruiting Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04411043recruiting Observatory of Prolymphocytic Leukemia T · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02007044Phase 2 · active not recruiting Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05418088Phase 1 · recruiting Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies · condition mapped CURATED_BROADER · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962636NA · terminated Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029443Phase 1/Phase 2 · active not recruiting ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771572Phase 1 · recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231412Phase 3 · completed Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03479268Phase 1 · active not recruiting Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356245Phase 2 · recruiting Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01589302Phase 2 · active not recruiting PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02296918Phase 1 · completed Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02005289Phase 2 · completed Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04191187Phase 2 · completed Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496349Phase 2 · recruiting A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL · condition mapped ALIAS · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02153580Phase 1 · active not recruiting Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05823571Phase 1 · active not recruiting Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722668Phase 2 · completed UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303392Phase 1 · completed Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05225584Phase 1 · completed Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04312841Phase 2 · completed Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526795Phase 1 · terminated Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia · condition mapped CURATED_BROADER · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420076Phase 1/Phase 2 · recruiting Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989466Phase 1 · completed Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia · condition mapped CURATED_BROADER · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661035Phase 2 · completed Allo HSCT Using RIC for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03010358Phase 1/Phase 2 · completed Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01029366Phase 1 · completed CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03873493Phase 2 · completed A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01886859Phase 1 · completed Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped CURATED_BROADER · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689453Phase 1 · completed Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186640Phase 2 · completed Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00546793Phase 1/Phase 2 · completed Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02991898Phase 2 · terminated Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309842Phase 2 · completed Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03097770Phase 1/Phase 2 · completed Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01629511Phase 1/Phase 2 · terminated Allogeneic Stem Cell Transplant for CLL · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005803Phase 1/Phase 2 · completed Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01527045Phase 2 · completed Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251575Phase 2 · completed Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530515Phase 2 · completed Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104858Phase 2 · completed Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008462Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03185494Phase 1/Phase 2 · unknown Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898079completed Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484015Phase 1 · completed Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129193Phase 1 · completed AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278213Phase 2 · completed Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01515176Phase 1/Phase 2 · completed Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060424Phase 2 · completed Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02662296Phase 2 · withdrawn Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01419795Phase 2 · terminated Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02285244Phase 2 · withdrawn Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742727Phase 1/Phase 2 · unknown CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02892695Phase 1/Phase 2 · unknown PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819583Phase 1/Phase 2 · unknown CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098371Phase 2 · terminated Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281931Phase 2 · terminated Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02851589Phase 1/Phase 2 · unknown Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | B-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01212380Phase 1 · completed Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864889NA · unknown Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01419691Phase 2 · completed Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076556Phase 1 · terminated Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01126502Phase 1 · terminated Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01735604Phase 1/Phase 2 · unknown Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00735930Phase 1 · completed Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343798Phase 1 · completed A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955668Phase 1 · completed AZD6738 First Time in Patient Multiple Ascending Dose Study · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129180Phase 1 · completed Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00612612Phase 1 · terminated Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749502Phase 1 · completed A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | T-Cell Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098488Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005786NA · terminated Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 95 trials mapped (20 active) | — | — | Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |